Per- and polyfluoroalkyl substances, Emerging PFAS, Prenatal exposure, Transplacental transfer
Perfluorinated compounds, Umbilical cord serum, LC-MS/MS, Method optimization, Pregnant exposure
magnetic solid phase extraction, Microporous organic network, β-Cyclodextrin, fluoroquinolone
perfluorooctane sulfonate, placenta, BeWo cells, steroid hormone secretion, Membrane transporters